BioNTech founders hopeful of a cancer vaccine within a decade
Scientists are hopeful of an mRNA based vaccine for cancer
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Scientists are hopeful of an mRNA based vaccine for cancer
The global response to combat the Covid-19 crisis lacked cooperation and coordination: WHO
Immune evasive BQ! strains spreading fast in the US and European countries
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
COVID-19 vaccine maker BioNTech inks research deal with Australia
Recurring global deadly disease outbreaks crippling economies
Saline nasal washes helpful in flushing out Covid-19 virus
HT team October 5, 2022: More than 500 global health workers across WHO’s six regions are meeting in Armenia to reflect on lessons.
HT team As the Covid-19 pandemic torments the world, scientists in the US have made a drug that brings the virus’s downfall. Chemicals.